반응식
[CH3:1][C:2]1[CH:14]=[CH:13][C:5]([CH2:6][CH:7]2[CH2:12][CH2:11][NH:10][CH2:9][CH2:8]2)=[CH:4][CH:3]=1.[CH2:15]([O:22][C:23]1[CH:32]=[CH:31][C:30]2[C:25](=[CH:26][CH:27]=[C:28]([O:33]CCBr)[CH:29]=2)[CH:24]=1)[C:16]1C=CC=CC=1.C(=O)([O-])[O-].[K+].[K+]>>[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([CH2:6][CH:7]2[CH2:12][CH2:11][N:10]([CH2:16][CH2:15][O:22][C:23]3[CH:24]=[C:25]4[C:30](=[CH:31][CH:32]=3)[CH:29]=[C:28]([OH:33])[CH:27]=[CH:26]4)[CH2:9][CH2:8]2)=[CH:13][CH:14]=1참가 물질
4
실험 절차
The title compound was prepared from 4-(4-Methylbenzyl)-piperidine and and 2-benzyloxy-6-(2-bromo-ethoxy)-naphthalene and potassium carbonate in two steps as a solid, mp 164-166° C. Analysis calculated for CH25H29O2 : C, 79.96; H, 7.78; N, 3.73. Found: C, 79.63; H, 7.84; N, 3.67.
출처 및 근거
- ORD 기록
- ord-e11da3beb4594ccfbbabf5001c0be4c7
- 출처 데이터셋
- uspto-grants-2000_09
- 특허 번호
- US06124323
연결된 노트
불러오는 중…